HCID 22711271, Verbindung → 4-[(6-Chloronaphthalen-2-yl)sulfonyl]-1-[(6-methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridin-2-yl)carbonyl]-2-[N-[[(morpholin-4-yl)carbonyl]methyl]carbamoyl]piperazine Hydrochloride

Beteiligte Stoffe

Rolle	Name	HCID	Einwaage
Edukt	HCID 22711271	HCID 22711271	—
Edukt	Lithium 6-methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridine-2-carboxylate	HCID 23674323	—
Produkt	4-[(6-Chloronaphthalen-2-yl)sulfonyl]-1-[(6-methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridin-2-yl)carbonyl]-2-[N-[[(morpholin-4-yl)carbonyl]methyl]carbamoyl]piperazine Hydrochloride	HCID 22711200	—

Reaktionsschritte

Starting materials : lithium 6-methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridine-2-carboxylate, 1-[(6-chloronaphthalen-2-yl)sulfonyl]-3-[N-[[(morpholin-4-yl)carbonyl]methyl]carbamoyl]piperazine hydrochloride

Herkunft & Nachweise

DOI	10.6084/m9.figshare.5104873.v1
Patentnummer	US06747023B1
Quelldatensatz	uspto-grants-2004_06
ORD ID	ord-ef9ccd77d8a8486da0142963f10bf270
Quellennotiz	uspto-grants-2004_06